The use of abciximab perfusion after stenting was questioned at the American Heart Association meeting in Dallas. The EASY study found bolus administration of glycoprotein 2B3A inhibition was sufficient and gives the possibility of sending patients home early.Olivier Bertrand, Hôpital Laval, Quebec.
Reporting from:
American Heart Association Annual Scientific Sessions November 13-16, 2005, Dallas
In this edition:
Bryan Williams told American Heart Association attendees that
Reporting from:
American Heart Association Annual Scientific Sessions November 13-16, 2005, Dallas
Scientific Editors:
Michael Petch, Papworth Hospital, Cambridge
Man Fai Shiu, Walsgrave Hospital,
Post a comment